CSI Market
Sign In | Register

Ispecimen inc (ISPC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ISPC Annual Cash Flow →
Looking at cash flow data from Ispecimen inc through Jun 30 2025 provides insight into Jun 30 2026's financial flexibility across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-3.64
Depreciation & amortization0.34
Amortization of Other Assets0.10
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Amortization Of Discount On Bridge Notes-
Change In Fair Value Of Derivative Liabilities-
Loss On Extinguishment Of Bridge Notes And Bridge Notes Related Parties-
Loss On Extinguishment Of Covertible Notes-
Accounts Receivable Unbilled-
Increase Decrease In Due From Factor-
Increase Decrease In Right Of Use Asset0.02
Proceeds From Issuance Of Common Stock For Services-
Amortization Of Financing Costs And Discounts On Notes Payable-
Increase Or Decrease In Tax Credit Receivable-
Capitalized Computer Software Amortization0.13
Allowance For Doubtful Accounts Receivable Write Offs-
Writeoff Of Internally Developed Software-
Gain Loss Related To Litigation Settlement-0.26
Increase Decrease In Contract With Customer Liability0.00
Income taxes0.00
Loss on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable-0.03
Increase (Decrease) in Accounts Payable-0.43
Increase (Decrease) in Accrued Liabilities0.00
Increase (Decrease) in Security Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.02
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.42
Discontinued operations0.00
Net Cash flow from Operating Activities-4.05
Investing Activities
Capital Expenditures-0.70
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Payments To Acquire Leasehold Improvements Included In Operating Lease Right Of Use Asset-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.70
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.29
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Over Allotment Shares Of Commonstock Net Of Transaction Cost-
Payment Of Principal To Bridge Note Holders-
Payments Of Offering Costs In Connection With Pipe-
Proceeds From Issuance Of Over Allotment Shares Of Common Stock Net Of Transaction Cost-
Adjustments To Paid In Capital Transaction Costs In Connection With Pipe-
Proceeds From Issuance Of Common Stock In Connection With At The Market Offering Agreement-
Proceeds From Prefunded Warrants-
Repurchase Of Common Stock Exercisable Under P I P E Warrants-
Payment Of Offering Costs In Connection With The Issuance Of Common Stock And Prefunded Warrants-
Repurchase Of Common Stock Purchase Warrants Exercisable Under P I P E Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.29
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-4.75
Total Cash Flow-2.47
4 historic quarters locked

Sign in to unlock the full Ispecimen inc cash flow history.

Sign In Create Free Account

About Ispecimen Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-090226

Figures are derived from filed reports and may be restated. Historical data is subject to revision.